RecruitingNot ApplicableNCT05643144

Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes

Enhancing Shared Decision-making to Prompt and Guide Individualized Care for People With Alzheimer's Disease and Diabetes


Sponsor

Indiana University

Enrollment

62 participants

Start Date

Jun 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Aim 1: Characterize shared decision-making and unmet patient-caregiver dyads needs for patients with diabetes and Alzheimer's Disease and related dementias (ADRD) while using a continuous glucose monitoring (CGM) device. Aim 2: Develop an interactive tool to enhance shared decision-making for diabetes management.


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is developing tools to improve shared decision-making between doctors, patients with both dementia and diabetes, and their caregivers — helping all parties make better decisions together about diabetes management when cognitive decline makes this more complicated. **You may be eligible if...** - The patient has both a diagnosis of mild cognitive impairment or dementia AND diabetes - The patient is taking at least one diabetes medication - The patient has had a visit to a participating primary care clinic in the last 12 months - The patient has a caregiver who interacts with them almost daily and is 18 or older - Both the patient and caregiver speak English and live in the community - Both have access to the internet **You may NOT be eligible if...** - The patient has a terminal illness - The patient uses an automated insulin pump - The caregiver does not interact with the patient regularly Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEContinuous Glucose Monitoring

CGM education and glucose data collection for 14 days with a device. Interviews with dyads to assess experience and awareness of hypoglycemic events.


Locations(1)

Eskenazi Health

Indianapolis, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05643144


Related Trials